Evidence map›Paper›PMID 16570923›Full record

ArticleJournal of medicinal chemistry2006

Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.

Yunpeng Ye, Sharon Bloch, Baogang Xu, Samuel Achilefu

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Phenothiazine-Biaryl-Containing Fluorescent RGD Peptides.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Article
  10. Article
  11. Review
  12. Synthesis and photophysical studies of a multivalent photoreactive RuBeilstein journal of organic chemistry · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yunpeng YeDepartment of Radiology, Washington University, St. Louis, Missouri 63110, USA.
Sharon Bloch
Baogang Xu
Samuel Achilefu
Washington University in St. Louis · US

Funding

WASHINGTON UNIVERSITY SMALL ANIMAL IMAGING RESOURCER24CA083060 · NCI · WASHINGTON UNIVERSITY · PI ACKERMAN, JOSEPH J. H. · 1999 to 2006
$4.8M
Optical Probes &Methods for Imaging Integrin ExpressionR01CA109754 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2004 to 2008
$2.9M
Novel Monomolecular Multi Modality Imaging AgentsR33CA100972 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2004 to 2006
$1.4M
Novel Monomolecular Multi Modality Imaging AgentsR21CA100972 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2003 to 2003
$153k
NCI NIH HHS R01 CA109754NCI NIH HHS R21 CA100972NCI NIH HHS R24 CA083060NCI NIH HHS R24 CA83060NCI NIH HHS R33 CA100972
6 · The paper itself

Abstract

Molecular interactions between RGD peptides and integrins are known to mediate many biological and pathological processes. This has led to an increased interest in the development of RGD compounds with high affinity and improved selectivity for integrin receptors. In this study, we synthesized and evaluated a series of multimeric RGD compounds constructed on a dicarboxylic acid-containing near-infrared (NIR) fluorescent dye (cypate) for tumor targeting. An array of NIR fluorescent RGD compounds was prepared efficiently, including one RGD monomer (cypate-(RGD)(2)-NH(2)), two RGD dimers (cypate-(RGD)(2)-NH(2) and cypate-(RGD-NH(2))(2)), one trimer (cypate-(RGD)(3)-NH(2)), two tetramers (cypate-(RGD)(4)-NH(2) and cypate-[(RGD)(2)-NH(2)](2)), one hexamer (cypate-[(RGD)(3)-NH(2)](2)), and one octamer (cypate-[(RGD)(4)-NH(2)](2)). The binding affinity of the multimeric RGD compounds for alpha(v)beta(3) integrin receptor (ABIR) showed a remarkable increase relative to the monomer cypate-RGD-NH(2). Generally, the divalent linear arrays of the multimeric RGD units bound the ABIR with slightly higher affinity than their monovalent analogues. These results suggest that the receptor binding affinity was not only dependent on the number of RGD moieties but also on the spatial alignments of the pendant peptides. Internalization of the compounds by ABIR-positive tumor cells (A549) was monitored by NIR fluorescence microscopy. The data showed that endocytosis of the octameric RGD derivative was significantly higher by comparison to other compounds in this study. In vivo noninvasive optical imaging and biodistribution data showed that the compounds were retained in A549 tumor tissue. These results clearly demonstrated that an array of simple RGD tripeptides on a NIR fluorescent dye core can be recognized by ABIR. Optimization of the spatial alignment of the RGD moieties through careful molecular design and library construction could induce multivalent ligand-receptor interactions useful for in vivo tumor imaging and tumor-targeted therapy.

Indexed as

AnimalsCarbocyaninesCell LineDrug DesignFluorescent DyesFluorometryHumansIntegrin alphaVbeta3MiceMice, NudeNeoplasms, ExperimentalNeoplasm TransplantationOligopeptidesStructure-Activity RelationshipTissue DistributionTransplantation, Heterologousarginyl-glycyl-aspartic acidCarbocyaninesFluorescent DyesIntegrin alphaVbeta3Oligopeptides

Identifiers

PMID16570923
PMCPMC2525663
OpenAlexW1973639818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.